Skip to main content
Top
Published in: International Journal of Diabetes in Developing Countries 4/2022

25-10-2021 | Gestational Diabetes | Original Article

Correlation analysis of triglycerides to high-density lipoprotein-cholesterol ratio associated with gestational diabetes mellitus

Authors: Md. Mim Obaidullah, Shirmin Islam, Md. Rayhan Chowdhury, Lubatul Arbia, Israt Ara Hossain, Mohammad Nurul Matin

Published in: International Journal of Diabetes in Developing Countries | Issue 4/2022

Login to get access

Abstract

Background

Gestational diabetes mellitus (GDM) initiates when a woman’s pancreas could not act appropriately to bypass the diabetogenic condition during pregnancy. It is increasing across the world, including Bangladesh. Triglycerides (TG) and high-density lipoprotein-cholesterol (HDLC) are strongly connected with insulin resistance in pregnant women.

Objectives

Observation of the role of lipid profiles and TG/HDL cholesterol ratio associated with fasting glucose in GDM subjects.

Methods

In this experiment, a total of 232 individual subjects consisting of 132 GDM-positive and 100 GDM-negative pregnant women were examined and observed from 24 to 28 weeks of their pregnancy period. For this study, we had collected blood samples from selected women before and after breakfast and analyzed blood glucose level, triglyceride cholesterol level, HDL, low-density lipoprotein (LDL), and TG/HDL ratio.

Results

TG and LDL-cholesterol were significantly higher (p < 0.001) in GDM individuals (220.95 ± 67.4 and 149.54 ± 32.4, respectively) than those of the non-GDM (160.98 ± 59.67 and 129.18 ± 34.18, respectively). On the contrary, HDL-cholesterol level was comparatively lower in GDM-positive women than non-GDM subjects. In this case, the optimum cut-off point was 3.8 for the TG/HDL-C ratio with 62% sensitivity and 78% specificity by oral glucose tolerance test (OGTT).

Conclusion

Significantly (p < 0.001) higher TG/HDL ratio was found in GDM women compared with those in non‐GDM. TG/HDL ratios are independently associated with the risks of GDM, which might be a good marker in predicting GDM risk.
Literature
1.
go back to reference Bharathi KR, Vijayalakshmi S, Shrunga RP. A study of lipid parameters among GDM and non GDM pregnant women: a hospital based study. Int J Reprod Contraception Obstet Gynecol. 2017;6:5488.CrossRef Bharathi KR, Vijayalakshmi S, Shrunga RP. A study of lipid parameters among GDM and non GDM pregnant women: a hospital based study. Int J Reprod Contraception Obstet Gynecol. 2017;6:5488.CrossRef
2.
go back to reference Van Assche FA, Aerts L, Holemans K. Metabolic alterations in adulthood after intrauterine development in mothers with mild diabetes. Diabetes. 1991;40:106–8.CrossRef Van Assche FA, Aerts L, Holemans K. Metabolic alterations in adulthood after intrauterine development in mothers with mild diabetes. Diabetes. 1991;40:106–8.CrossRef
3.
go back to reference Van Assche FA, Aerts L, Holemans K. Maternal diabetes and the effect for the offspring. Verh K Acad Geneeskd Belg. 1992;54. Van Assche FA, Aerts L, Holemans K. Maternal diabetes and the effect for the offspring. Verh K Acad Geneeskd Belg. 1992;54.
4.
go back to reference Rosenn B, Tsang RC. The effects of maternal diabetes on the fetus and neonate. Ann Clin Lab Sci. 1991;21:153–70. Rosenn B, Tsang RC. The effects of maternal diabetes on the fetus and neonate. Ann Clin Lab Sci. 1991;21:153–70.
5.
go back to reference American College of Obstetricians and Gynecologists. Assessment of risk factors for preterm birth. Clinical management guidelines for obstetrician-gynecologists. ACOG Practice Bulletin. 2001; 31. American College of Obstetricians and Gynecologists. Assessment of risk factors for preterm birth. Clinical management guidelines for obstetrician-gynecologists. ACOG Practice Bulletin. 2001; 31.
6.
go back to reference Mohiuddin AK. Diabetes fact: Bangladesh perspective. Int J Diabetes Res. 2019;2:14–20. Mohiuddin AK. Diabetes fact: Bangladesh perspective. Int J Diabetes Res. 2019;2:14–20.
7.
go back to reference American Diabetes Association. Gestational diabetes mellitus (Position Statement). Diabetes Care. 2004;27(Suppl. 1):S88-90.CrossRef American Diabetes Association. Gestational diabetes mellitus (Position Statement). Diabetes Care. 2004;27(Suppl. 1):S88-90.CrossRef
8.
go back to reference Cheung NW, Wasmer G, Al-Ali J. Risk factors for gestational diabetes among Asian women. Diabetes Care. 2001;24:955–6.CrossRef Cheung NW, Wasmer G, Al-Ali J. Risk factors for gestational diabetes among Asian women. Diabetes Care. 2001;24:955–6.CrossRef
9.
go back to reference Wang Y, Zhao X, Zhao H, Ding H, Tan J, Chen J, et al. Risks for gestational diabetes mellitus and pregnancy-induced hypertension are increased in polycystic ovary syndrome. Biomed Res Int. 2013;2013. Wang Y, Zhao X, Zhao H, Ding H, Tan J, Chen J, et al. Risks for gestational diabetes mellitus and pregnancy-induced hypertension are increased in polycystic ovary syndrome. Biomed Res Int. 2013;2013.
10.
go back to reference Monir N, Zeba Z, Rahman A. Comparison of knowledge of women with gestational diabetes mellitus and healthy pregnant women attending at hospital in Bangladesh. J Sci Found. 2018;16:20–6.CrossRef Monir N, Zeba Z, Rahman A. Comparison of knowledge of women with gestational diabetes mellitus and healthy pregnant women attending at hospital in Bangladesh. J Sci Found. 2018;16:20–6.CrossRef
11.
go back to reference Li G, Kong L, Zhang L, Fan L, Su Y, Rose JC, et al. Early pregnancy maternal lipid profiles and the risk of gestational diabetes mellitus stratified for body mass index. Reprod Sci. 2015;22:712–7.CrossRef Li G, Kong L, Zhang L, Fan L, Su Y, Rose JC, et al. Early pregnancy maternal lipid profiles and the risk of gestational diabetes mellitus stratified for body mass index. Reprod Sci. 2015;22:712–7.CrossRef
12.
go back to reference Zhu WW, Yang HX, Wei YM, Yan J, Wang ZL, Li XL, Wu HR, Li N, Zhang MH, Liu XH, Zhang H. Evaluation of the value of fasting plasma glucose in the first prenatal visit to diagnose gestational diabetes mellitus in China. Diabetes Care. 2013;36:586–90.CrossRef Zhu WW, Yang HX, Wei YM, Yan J, Wang ZL, Li XL, Wu HR, Li N, Zhang MH, Liu XH, Zhang H. Evaluation of the value of fasting plasma glucose in the first prenatal visit to diagnose gestational diabetes mellitus in China. Diabetes Care. 2013;36:586–90.CrossRef
13.
go back to reference Nolan CJ, Riley SF, Sheedy MT, Walstab JE, Beischer NA. Maternal serum triglyceride, glucose tolerance, and neonatal birth weight ratio in pregnancy: a study within a racially heterogeneous population. Diabetes Care. 1995;18:1550–6.CrossRef Nolan CJ, Riley SF, Sheedy MT, Walstab JE, Beischer NA. Maternal serum triglyceride, glucose tolerance, and neonatal birth weight ratio in pregnancy: a study within a racially heterogeneous population. Diabetes Care. 1995;18:1550–6.CrossRef
14.
go back to reference Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol. 1982;144(7):768–73.CrossRef Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol. 1982;144(7):768–73.CrossRef
16.
go back to reference Monteiro LJ, Norman JE, Rice GE, Illanes SE. Fetal programming and gestational diabetes mellitus. Placenta. 2016;48:S54-60.CrossRef Monteiro LJ, Norman JE, Rice GE, Illanes SE. Fetal programming and gestational diabetes mellitus. Placenta. 2016;48:S54-60.CrossRef
17.
go back to reference Dorner G, Plagemann A, Reinagel H. Familial diabetes aggregation in type I 532 diabetics: gestational diabetes an apparent risk factor for increased diabetes 533 susceptibility in the offspring. Exp Clin Endocrinol. 1987;89:84–90.CrossRef Dorner G, Plagemann A, Reinagel H. Familial diabetes aggregation in type I 532 diabetics: gestational diabetes an apparent risk factor for increased diabetes 533 susceptibility in the offspring. Exp Clin Endocrinol. 1987;89:84–90.CrossRef
18.
go back to reference Bartha JL, Comino-Delgado R, Martinez-Del-Fresno P, Fernandez-Barrios M, Bethencourt I, Moreno-Corral L. Insulin-sensitivity index and carbohydrate and lipid metabolism in gestational diabetes. J Reprod Med Obstet Gynecol. 2000;45:185–9. Bartha JL, Comino-Delgado R, Martinez-Del-Fresno P, Fernandez-Barrios M, Bethencourt I, Moreno-Corral L. Insulin-sensitivity index and carbohydrate and lipid metabolism in gestational diabetes. J Reprod Med Obstet Gynecol. 2000;45:185–9.
19.
go back to reference Clark CM, Qiu C, Amerman B, Porter B, Fineberg N, Aldasouqi S, Golichowski A. Gestational diabetes: should it be added to the syndrome of insulin resistance? Diabetes Care. 1997;20:867–71.CrossRef Clark CM, Qiu C, Amerman B, Porter B, Fineberg N, Aldasouqi S, Golichowski A. Gestational diabetes: should it be added to the syndrome of insulin resistance? Diabetes Care. 1997;20:867–71.CrossRef
20.
go back to reference Couch SC, Philipson EH, Bendel RB, Wijendran V, Lammi-Keefe CJ. Maternal and cord plasma lipid and lipoprotein concentrations in women with and without gestational diabetes mellitus: predictors of birth weight? J Reprod Med Obstet Gynecol. 1998;43:816–22. Couch SC, Philipson EH, Bendel RB, Wijendran V, Lammi-Keefe CJ. Maternal and cord plasma lipid and lipoprotein concentrations in women with and without gestational diabetes mellitus: predictors of birth weight? J Reprod Med Obstet Gynecol. 1998;43:816–22.
21.
go back to reference Barat S, Ghanbarpour A, Bouzari Z, Batebi Z. Triglyceride to HDL cholesterol ratio and risk for gestational diabetes and birth of a large-for-gestational-age newborn. Casp J Intern Med. 2018;9:368–75. Barat S, Ghanbarpour A, Bouzari Z, Batebi Z. Triglyceride to HDL cholesterol ratio and risk for gestational diabetes and birth of a large-for-gestational-age newborn. Casp J Intern Med. 2018;9:368–75.
22.
go back to reference Russell MA, Carpenter MW, Coustan DR. Screening and diagnosis of gestational diabetes mellitus. Clin Obstet Gynecol. 2007;50:949–58.CrossRef Russell MA, Carpenter MW, Coustan DR. Screening and diagnosis of gestational diabetes mellitus. Clin Obstet Gynecol. 2007;50:949–58.CrossRef
23.
go back to reference Wang J, Li Z, Lin L. Maternal lipid profiles in women with and without gestational diabetes mellitus. Medicine (Baltimore). 2019;98:e15320.CrossRef Wang J, Li Z, Lin L. Maternal lipid profiles in women with and without gestational diabetes mellitus. Medicine (Baltimore). 2019;98:e15320.CrossRef
24.
go back to reference Donovan BM, Spracklen CN, Schweizer ML, Ryckman KK, Saftlas AF. Intimate partner violence during pregnancy and the risk for adverse infant outcomes: a systematic review and meta-analysis. BJOG An Int J Obstet Gynaecol. 2016;123:1289–99.CrossRef Donovan BM, Spracklen CN, Schweizer ML, Ryckman KK, Saftlas AF. Intimate partner violence during pregnancy and the risk for adverse infant outcomes: a systematic review and meta-analysis. BJOG An Int J Obstet Gynaecol. 2016;123:1289–99.CrossRef
25.
go back to reference Meshkini M, Alaei-Shahmiri F, Mamotte C, Earnest J. Ethnic variation in lipid profile and its associations with body composition and diet: differences between Iranians, Indians and Caucasians living in Australia. J Immigr Minor Heal. 2017;19:67–73.CrossRef Meshkini M, Alaei-Shahmiri F, Mamotte C, Earnest J. Ethnic variation in lipid profile and its associations with body composition and diet: differences between Iranians, Indians and Caucasians living in Australia. J Immigr Minor Heal. 2017;19:67–73.CrossRef
26.
go back to reference Feingold K, Brinton EA, Grunfeld C. The effect of endocrine disorders on lipids and lipoproteins. Endotext. 2020. Feingold K, Brinton EA, Grunfeld C. The effect of endocrine disorders on lipids and lipoproteins. Endotext. 2020.
27.
go back to reference Sikaris KA. The clinical biochemistry of obesity. Clin Biochem Rev. 2004;25:165–81. Sikaris KA. The clinical biochemistry of obesity. Clin Biochem Rev. 2004;25:165–81.
28.
go back to reference Bahrami H, Sadatsafavi M, Pourshams A, Kamangar F, Nouraei M, Semnani S, et al. Obesity and hypertension in an Iranian cohort study; Iranian women experience higher rates of obesity and hypertension than American women. BMC Public Health. 2006;6. Bahrami H, Sadatsafavi M, Pourshams A, Kamangar F, Nouraei M, Semnani S, et al. Obesity and hypertension in an Iranian cohort study; Iranian women experience higher rates of obesity and hypertension than American women. BMC Public Health. 2006;6.
29.
go back to reference Lakshmi AS, Lakshmanan A, Ganesh Kumar P, Saravanan A. Effect of intensity of cigarette smoking on haematological and lipid parameters. J Clin Diagnostic Res. 2014;8. Lakshmi AS, Lakshmanan A, Ganesh Kumar P, Saravanan A. Effect of intensity of cigarette smoking on haematological and lipid parameters. J Clin Diagnostic Res. 2014;8.
30.
go back to reference Rashan MA, Dawood OT, Razzaq HAA, Hassali MA. The impact of cigarette smoking on lipid profile among Iraqi smokers. Int J Collab Res Intern Med Public Heal. 2016;8. Rashan MA, Dawood OT, Razzaq HAA, Hassali MA. The impact of cigarette smoking on lipid profile among Iraqi smokers. Int J Collab Res Intern Med Public Heal. 2016;8.
31.
go back to reference Halimi L, Haghdoost AA, Alizadeh SM. Prevalence of cigarette smoking among Iranian women: a systematic review and meta-analysis. Med J Islam Repub Iran. 2013;27:132–40. Halimi L, Haghdoost AA, Alizadeh SM. Prevalence of cigarette smoking among Iranian women: a systematic review and meta-analysis. Med J Islam Repub Iran. 2013;27:132–40.
32.
go back to reference Mansouri M, Sadeghi O, Roshanfekr P, Sharifi F, Varmaghani M, Yaghubi H, et al. Prevalence of smoking and its association with health-related behaviours among Iranian university students: a large-scale study. East Mediterr Heal J. 2020; Mansouri M, Sadeghi O, Roshanfekr P, Sharifi F, Varmaghani M, Yaghubi H, et al. Prevalence of smoking and its association with health-related behaviours among Iranian university students: a large-scale study. East Mediterr Heal J. 2020;
33.
go back to reference Bao W, Dar S, Zhu Y, Wu J, Rawal S, Li S, et al. Plasma concentrations of lipids during pregnancy and the risk of gestational diabetes mellitus: a longitudinal study. J Diabetes. 2018;10:487–95.CrossRef Bao W, Dar S, Zhu Y, Wu J, Rawal S, Li S, et al. Plasma concentrations of lipids during pregnancy and the risk of gestational diabetes mellitus: a longitudinal study. J Diabetes. 2018;10:487–95.CrossRef
34.
go back to reference Ryckman KK, Spracklen CN, Smith CJ, Robinson JG, Saftlas AF. Maternal lipid levels during pregnancy and gestational diabetes: a systematic review and meta-analysis. BJOG An Int J Obstet Gynaecol. 2015;122:643–51.CrossRef Ryckman KK, Spracklen CN, Smith CJ, Robinson JG, Saftlas AF. Maternal lipid levels during pregnancy and gestational diabetes: a systematic review and meta-analysis. BJOG An Int J Obstet Gynaecol. 2015;122:643–51.CrossRef
35.
go back to reference Jameshorani M, Arefzadeh A, Khalighinejad P, Ranjbar S, Mazloomzadeh S. Evaluation of triglyceride to high-density lipoprotein cholesterol ratio and atherogenic indices in gestational diabetes mellitus. J Pharm Res Int. 2018;22:1–9.CrossRef Jameshorani M, Arefzadeh A, Khalighinejad P, Ranjbar S, Mazloomzadeh S. Evaluation of triglyceride to high-density lipoprotein cholesterol ratio and atherogenic indices in gestational diabetes mellitus. J Pharm Res Int. 2018;22:1–9.CrossRef
Metadata
Title
Correlation analysis of triglycerides to high-density lipoprotein-cholesterol ratio associated with gestational diabetes mellitus
Authors
Md. Mim Obaidullah
Shirmin Islam
Md. Rayhan Chowdhury
Lubatul Arbia
Israt Ara Hossain
Mohammad Nurul Matin
Publication date
25-10-2021
Publisher
Springer India
Published in
International Journal of Diabetes in Developing Countries / Issue 4/2022
Print ISSN: 0973-3930
Electronic ISSN: 1998-3832
DOI
https://doi.org/10.1007/s13410-021-01016-5

Other articles of this Issue 4/2022

International Journal of Diabetes in Developing Countries 4/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine